RxDoctor Payments Data

Joseph Wilson, MD

Orthopaedic Surgery · Durham, NCNPI 1497915698

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 84.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $266 and has fallen 94.2% since, to $16 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NC, where the typical reported total is $4,547.

$715in general payments, 2019–2025

Across 9 payments — averaging $79.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$607
  • Linvatec Corporation$81
  • Crossroads Orthopedics, LLC$15
  • Convatec Inc.$12
$75,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $10,714 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$75K

What the payments were for

  • Food & beverage$715100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)6$607
Linvatec Corporation1$81
Crossroads Orthopedics, LLC1$15
Convatec Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$715 in reported general payments places this provider in the 20th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024
$186,881
Medicare patients
313
Services billed
1,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl389$3,888
Methylprednisolone280$1,605
Meloxicam300$1,328
Tramadol Hcl192$572
Celecoxib27$445
Oxycodone Hcl25$177
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$167
Ibuprofen17$95
Amoxicillin16$66
Diazepam11$5

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Durham

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →